These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 3249589)

  • 1. [Effect of Pseudomonas carnea--the active principle of a microbial insecticide--on the body of animals].
    Omel'ianets TG
    Mikrobiol Zh (1978); 1988; 50(5):80-3. PubMed ID: 3249589
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of experimental Pseudomonas aeruginosa infection on the activity of mouse phagocytes.
    Izdebska-Szymona K; Nowakowska K; Sitnicka E
    Arch Immunol Ther Exp (Warsz); 1983; 31(4):511-5. PubMed ID: 6670920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interaction of bacteria-destructors of the Pseudomonas genus with a culture of rabbit alveolar macrophages].
    Tul'chinskaia VP; Gudzenko TV; Kalmazan LA; Kozhanova GA; Sinenko GI
    Mikrobiol Zh (1978); 1984; 46(6):26-30. PubMed ID: 6400809
    [No Abstract]   [Full Text] [Related]  

  • 4. [L-transformation of the causative agents as one of the routes for the realization of a chronic Pseudomonas bacterial carrier state].
    Zamaraev VS; Iliukhin VI; Saiamov SR; Riapis LA
    Mikrobiol Zh (1978); 1987; 49(3):91-6. PubMed ID: 3508941
    [No Abstract]   [Full Text] [Related]  

  • 5. The importance of extracellular antigens in Pseudomonas cepacia infections.
    Straus DC; Woods DE; Lonon MK; Garner CW
    J Med Microbiol; 1988 Aug; 26(4):269-80. PubMed ID: 3135408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Reduced phagocytosis in immunized animals].
    Pal'tsyn AA; Kolokol'chikova EG; Badikova AK; Chervonskaia NV; Grishina IA
    Biull Eksp Biol Med; 1996 Sep; 122(9):348-52. PubMed ID: 8974498
    [No Abstract]   [Full Text] [Related]  

  • 7. [Characterization of a Chrysemonas luteola strain isolated from a healthy carrier and investigation of pathogenicity, virulence and antibiotic resistance factors through in vitro and in vivo studies].
    Israil A; Balotescu C; Alexandru I
    Bacteriol Virusol Parazitol Epidemiol; 2004; 49(1-2):43-7. PubMed ID: 16752751
    [No Abstract]   [Full Text] [Related]  

  • 8. [The protective properties of Pseudomonas aeruginosa anatoxin].
    Dziuban NF; Podgornaia LG
    Mikrobiol Zh (1978); 1985; 47(2):83-6. PubMed ID: 3939835
    [No Abstract]   [Full Text] [Related]  

  • 9. [The effect of antibodies to microorganisms in a focus of purulent inflammation].
    Pal'tsyn AA; Kolokol'chikova EG; Grishina IA; Chervonskaia NV; Badikova AK; Popova EP
    Arkh Patol; 1994; 56(5):15-9. PubMed ID: 7695487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of experimental Pseudomonas aeruginosa infection with carbenicillin and antiserum. Dose-effect relations].
    Mai K; Eckhardt R
    Arzneimittelforschung; 1972 Apr; 22(4):809-13. PubMed ID: 4626081
    [No Abstract]   [Full Text] [Related]  

  • 11. [Protective effect of Pseudomonas-specific immunoglobulin from the rabbit and of active immunization in experimental Pseudomonas sepsis in mice].
    Trautmann M; Brückner O; Hahn H
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jul; 252(3):370-83. PubMed ID: 6215803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pseudomonas maltophilia as an agent of infection in man (author's transl)].
    Fritsche D; Lütticken R; Böhmer H
    Zentralbl Bakteriol Orig A; 1974; 229(1):89-97. PubMed ID: 4155214
    [No Abstract]   [Full Text] [Related]  

  • 13. Toxicity studies of microbial insecticide Bacillus thuringiensis var. kenyae in rats, rabbits, and fish.
    Meher SM; Bodhankar SL; Arunkumar ; Dhuley JN; Khodape DJ; Naik SR
    Int J Toxicol; 2002; 21(2):99-105. PubMed ID: 12022636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoserology of Pseudomonas aeruginosa infections in man. II. effect of natural and immune anti-LPS antibodies on pseudomonas colonization and infection.
    Petrás G; Adám MM; Lányi B; Konkoly Thege M; Szentmihályi A
    Acta Microbiol Hung; 1984; 31(2):101-8. PubMed ID: 6431739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron dictates the virulence of Pseudomonas aeruginosa in urinary tract infections.
    Mittal R; Sharma S; Chhibber S; Harjai K
    J Biomed Sci; 2008 Nov; 15(6):731-41. PubMed ID: 18688758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudomonas cepacia.
    Gregory WJ; McNabb PC
    Infect Control; 1986 May; 7(5):281-4. PubMed ID: 3519497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [CLearance of Pseudomonas aeruginosa from the lungs in experimental burn trauma].
    Matveeva EA; Galankin VN; Kolker II; Botsmanov KV
    Arkh Patol; 1981; 43(6):59-64. PubMed ID: 6791616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased clearance of Pseudomonas aeruginosa from airways of mice deficient in lysozyme M.
    Cole AM; Thapa DR; Gabayan V; Liao HI; Liu L; Ganz T
    J Leukoc Biol; 2005 Nov; 78(5):1081-5. PubMed ID: 16204648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The protective effect of anti-Pseudomonas blood preparations].
    Nazarchuk LV; Koval' AI
    Fiziol Zh (1994); 2001; 47(6):55-7. PubMed ID: 11962093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploitation of syndecan-1 shedding by Pseudomonas aeruginosa enhances virulence.
    Park PW; Pier GB; Hinkes MT; Bernfield M
    Nature; 2001 May; 411(6833):98-102. PubMed ID: 11333985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.